JSPR Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 2.70%

Insider Buying (Last 12 Months): $4,532,500.00

Insider Selling (Last 12 Months): $64,647.00

Jasper Therapeutics Insider Trading History Chart

Jasper Therapeutics Share Price & Price History

^$22.05

▲ +0.21 (0.96%)

As of 11/22/2024 01:00 AM ET

Days: 30 | 90 | 365

“Fed Proof” Your Bank Account with THESE 4 Simple Steps

From Weiss Ratings | Ad

Starting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide. It will give them unprecedented powers to control your bank account.

Learn these 4 simple steps and protect your savings before it’s too late.

Jasper Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
9/12/2024	Jeetinder Singh Mahal	COO	Sell	900	$21.23	$19,107.00	25,009
6/12/2024	Jeetinder Singh Mahal	COO	Sell	900	$24.16	$21,744.00	25,009
3/12/2024	Jeetinder Singh Mahal	COO	Sell	900	$26.44	$23,796.00	25,009
2/8/2024	Velan Capital Investment Manag	Major Shareholder	Buy	350,000	$12.95	$4,532,500.00	1,188,500
11/20/2023	Thomas G Wiggans	Director	Buy	1,000	$6.30	$6,300.00	3,000
11/16/2023	Thomas G Wiggans	Director	Buy	1,000	$6.00	$6,000.00	1,000
10/13/2023	William Lis	Director	Sell	796	$8.50	$6,766.00	5,352
6/13/2023	Jeetinder Singh Mahal	Insider	Sell	900	$16.60	$14,940.00	28,722
4/14/2023	Anna Louise French	Director	Sell	700	$14.80	$10,360.00	2,375
1/27/2023	Carlyle Group Inc.	Major Shareholder	Buy	313,333	$15.00	$4,699,995.00	876,189
1/25/2023	Holding Ltd Roche	Major Shareholder	Sell	7,500	$18.90	$141,750.00	454,960
6/27/2022	William Lis	Director	Sell	2,474	$20.80	$51,459.20	4,048
6/24/2022	William Lis	Director	Sell	2,474	$20.20	$49,974.80	6,522

Top secret Trump trades?

From Insiders Exposed | Ad

As you likely know, the “Trump bump” launched stocks to record highs after he secured his second reelection bid. Now, Trump and his team are coming to gut government regulation – and it’s going to create some incredible market opportunities. But while the masses chase large-cap tech and so-called AI stocks, a small circle of traders are using a strange but tactical method to find a pool of “hidden Trump trades.”

Go here to see how you can start accessing these opportunities today

SEC Filings (Institutional Ownership Changes) for Jasper Therapeutics (NASDAQ:JSPR)

79.85% of Jasper Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Jasper Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/19/2024	Barclays PLC	16,146	$0.30M	0.0%	+320.7%	0.108%
11/16/2024	Geode Capital Management LLC	257,416	$4.84M	0.0%	-0.9%	1.704%
11/15/2024	Barclays PLC	16,146	$0.30M	0.0%	+320.7%	0.107%
11/15/2024	Jane Street Group LLC	13,354	$0.25M	0.0%	N/A	0.088%
11/15/2024	Wellington Management Group LLP	23,759	$0.45M	0.0%	N/A	0.157%
11/15/2024	State Street Corp	214,883	$4.04M	0.0%	+12.3%	1.423%
11/15/2024	Samsara BioCapital LLC	584,642	$11M	2.1%	+11.4%	3.872%
11/15/2024	Ikarian Capital LLC	55,175	$1.04M	0.1%	-47.5%	0.365%
11/14/2024	Braidwell LP	483,300	$9.09M	0.3%	N/A	3.201%
11/14/2024	Verition Fund Management LLC	25,353	$0.48M	0.0%	N/A	0.168%
11/14/2024	Ally Bridge Group NY LLC	399,466	$7.51M	4.0%	+82.7%	2.645%
11/14/2024	MetLife Investment Management LLC	6,874	$0.13M	0.0%	+129.1%	0.046%
11/13/2024	Great Point Partners LLC	322,380	$6.06M	1.8%	-19.8%	2.135%
11/13/2024	BNP Paribas Financial Markets	2,512	$47K	0.0%	+208.6%	0.017%
11/13/2024	FMR LLC	38,361	$0.72M	0.0%	N/A	0.254%
10/30/2024	AlphaCentric Advisors LLC	17,500	$0.33M	0.2%	N/A	0.116%
10/29/2024	Fernwood Investment Management LLC	52,897	$1M	0.3%	+6.9%	0.351%
10/16/2024	Wolff Wiese Magana LLC	3,146	$59K	0.0%	N/A	0.021%
8/14/2024	Great Point Partners LLC	402,015	$9.13M	1.7%	-1.4%	2.669%
8/14/2024	Ally Bridge Group NY LLC	218,614	$4.96M	3.0%	-24.6%	1.451%
8/8/2024	American Century Companies Inc.	14,204	$0.32M	0.0%	+27.1%	0.094%
8/1/2024	Rhumbline Advisers	13,231	$0.30M	0.0%	N/A	0.088%
7/26/2024	Bank of New York Mellon Corp	32,579	$0.74M	0.0%	N/A	0.216%
5/29/2024	Opaleye Management Inc.	435,573	$12.79M	2.8%	-89.1%	2.892%
5/20/2024	Virtu Financial LLC	10,410	$0.31M	0.0%	N/A	0.069%
5/17/2024	Ikarian Capital LLC	105,175	$3.09M	0.3%	N/A	0.698%
5/16/2024	Kingdon Capital Management L.L.C.	497,000	$14.59M	1.6%	-86.0%	3.300%
5/14/2024	Qiming U.S. Ventures Management LLC	928,964	$27.27M	30.4%	-89.1%	6.168%
5/14/2024	StemPoint Capital LP	129,211	$3.79M	1.0%	N/A	0.858%
5/10/2024	Vanguard Group Inc.	612,745	$17.99M	0.0%	-85.0%	4.069%
5/8/2024	Russell Investments Group Ltd.	79,811	$2.34M	0.0%	N/A	0.530%
5/7/2024	Concurrent Investment Advisors LLC	20,409	$0.60M	0.0%	N/A	0.136%
5/3/2024	Carlyle Group Inc.	1,066,189	$31.30M	2.0%	-87.8%	7.080%
3/18/2024	Kingdon Capital Management L.L.C.	3,540,000	$2.79M	0.3%	+16.4%	31.720%
2/15/2024	Opaleye Management Inc.	3,985,340	$3.14M	0.8%	N/A	35.717%
2/7/2024	Ieq Capital LLC	54,500	$43K	0.0%	N/A	0.488%
2/7/2024	Monaco Asset Management SAM	249,563	$0.20M	0.1%	N/A	2.236%
2/5/2024	Fernwood Investment Management LLC	494,706	$0.39M	0.1%	+8.8%	4.433%
11/13/2023	Mariner LLC	652,749	$0.46M	0.0%	-8.7%	0.589%
11/9/2023	Cowen AND Company LLC	200,393	$0.14M	0.0%	N/A	0.181%
11/8/2023	Forefront Analytics LLC	110,792	$78K	0.0%	+59.7%	0.100%
10/30/2023	Summit Trail Advisors LLC	65,000	$46K	0.0%	N/A	0.059%
8/15/2023	Sphera Funds Management LTD.	4,274,008	$5.86M	0.9%	+5.7%	3.874%
8/14/2023	Jefferies Financial Group Inc.	489,884	$0.67M	0.0%	N/A	0.444%
6/1/2023	Prelude Capital Management LLC	54,500	$99K	0.0%	N/A	0.049%
5/16/2023	Ally Bridge Group NY LLC	2,517,232	$4.56M	6.0%	N/A	2.301%
5/16/2023	BVF Inc. IL	9,900,000	$17.92M	0.7%	N/A	9.051%
5/15/2023	Affinity Asset Advisors LLC	476,948	$0.86M	0.3%	N/A	0.436%
5/15/2023	Kingdon Capital Management L.L.C.	3,040,000	$5.50M	1.0%	+463.0%	2.779%
5/15/2023	RTW Investments LP	2,329,809	$4.22M	0.1%	N/A	2.130%
5/12/2023	Forefront Analytics LLC	30,290	$55K	0.0%	-73.4%	0.028%
5/5/2023	Carlyle Group Inc.	8,761,891	$15.77M	0.5%	N/A	8.011%
5/3/2023	Jump Financial LLC	33,074	$60K	0.0%	N/A	0.030%
4/25/2023	Qiming U.S. Ventures Management LLC	8,519,648	$15.42M	18.7%	+45.6%	7.789%
2/13/2023	Forefront Analytics LLC	114,000	$55K	0.0%	-4.8%	0.300%
2/7/2023	Fernwood Investment Management LLC	454,706	$0.22M	0.1%	+53.1%	1.197%
11/14/2022	Forefront Analytics LLC	119,800	$94K	0.1%	+246.0%	0.327%
11/9/2022	Fernwood Investment Management LLC	297,080	$0.23M	0.1%	N/A	0.810%
5/10/2022	Sectoral Asset Management Inc.	675,000	$2.40M	0.4%	N/A	1.782%
5/9/2022	Forefront Analytics LLC	32,550	$0.12M	0.0%	N/A	0.086%
4/27/2022	Vahanian & Associates Financial Planning Inc.	10,000	$36K	0.1%	-60.0%	0.026%
2/15/2022	Kingdon Capital Management L.L.C.	540,000	$4.24M	0.5%	N/A	1.427%
2/2/2022	Grace Capital	218,110	$1.71M	1.0%	N/A	0.576%
1/28/2022	Vahanian & Associates Financial Planning Inc.	25,000	$0.20M	0.2%	N/A	0.066%
11/16/2021	Citadel Advisors LLC	3,005,035	$29.22M	0.0%	N/A	8.228%
11/15/2021	Tudor Investment Corp Et Al	20,000	$0.21M	0.0%	N/A	0.055%
11/15/2021	Abingworth LLP	5,628,558	$58.03M	13.2%	N/A	15.412%

Data available starting January 2016

Jasper Therapeutics, Inc., a clinical-stage biotechnology company, develops therapeutic agents for hematopoietic stem cell transplantation and gene therapies. The company's lead product candidate is briquilimab, which is in clinical development as a novel therapeutic antibody that clears hematopoietic stem cells from bone marrow in patients prior to undergoing allogeneic stem cell therapy or stem cell gene therapy. It focuses on the development and commercialization of therapeutic agents for diseases, such as chronic spontaneous urticaria, lower to intermediate risk myelodysplastic syndrome, and conditioning regimens for stem cell transplantation. In addition, it is also developing stem cell transplants for rare diseases such as sickle cell disease, fanconi anemia, chronic granulomatous diseases, and GATA2 MDS, and severe combined immunodeficiency. Jasper Therapeutics, Inc. is headquartered in Redwood City, California.

Today's Range

Now: $22.05

$21.85

$22.55

50 Day Range

MA: $20.27

$14.72

$24.73

52 Week Range

Now: $22.05

$4.00

$31.01

Volume

185,525 shs

Average Volume

249,238 shs

Market Capitalization

$330.77 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.19

Who are the company insiders with the largest holdings of Jasper Therapeutics?: Jasper Therapeutics' top insider investors include:
Velan Capital Investment Manag (Major Shareholder)
Carlyle Group Inc (Major Shareholder)
Holding Ltd Roche (Major Shareholder)
Jeetinder Singh Mahal (Insider)
Jeetinder Singh Mahal (COO)
William Lis (Director)
Thomas G Wiggans (Director)
Anna Louise French (Director)
Learn More about top insider investors at Jasper Therapeutics.
Who are the major institutional investors of Jasper Therapeutics?: Jasper Therapeutics' top institutional shareholders include:
Samsara BioCapital LLC — 3.87%
Braidwell LP — 3.20%
Ally Bridge Group NY LLC — 2.65%
Great Point Partners LLC — 2.13%
Geode Capital Management LLC — 1.70%
State Street Corp — 1.42%
Learn More about top institutional investors of Jasper Therapeutics stock.
Which institutional investors are selling Jasper Therapeutics stock?: During the last quarter, JSPR stock was sold by these institutional investors:
Great Point Partners LLC
Ikarian Capital LLC
Geode Capital Management LLC
Which institutional investors are buying Jasper Therapeutics stock?: During the previous quarter, JSPR stock was acquired by institutional investors including:
Braidwell LP
Ally Bridge Group NY LLC
Samsara BioCapital LLC
FMR LLC
Verition Fund Management LLC
Wellington Management Group LLP
State Street Corp
AlphaCentric Advisors LLC
Within the previous year, these company insiders have bought Jasper Therapeutics stock:
Velan Capital Investment Manag (Major Shareholder)
Carlyle Group Inc (Major Shareholder)
Holding Ltd Roche (Major Shareholder)
Learn More investors buying Jasper Therapeutics stock.